Michael Srienc

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial.

Zev A Wainberg, Jason M Link, Alykhan Premji

Pageof 1

Frequent Collaborators

1 joint publications

Zev A Wainberg

1 joint publications

Jason M Link

1 joint publications

Serena Zheng

1 joint publications

Chi-Hong Tseng

1 joint publications

Caius G Radu

1 joint publications

Timothy R Donahue

Frequent Collaborators

1 joint publications

Zev A Wainberg

1 joint publications

Jason M Link

1 joint publications

Serena Zheng

1 joint publications

Chi-Hong Tseng

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

1.5K
See more related videos

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

1.5K
See more related videos